The expression and role of tyrosine kinase ETK/BMX in renal cell carcinoma

被引：0
作者：
Jintao Zhuang
Xiangan Tu
Kaiyuan Cao
Shengjie Guo
Xiaopeng Mao
Jincheng Pan
Bin Huang
Xu Chen
Yong Gao
Shaopeng Qiu
机构：
[1] Sun Yat-sen University,Department of Urology, The First Affiliated Hospital
[2] Sun Yat-sen University,Research Center for Clinical Laboratory Standard, Zhongshan Medical School
[3] Sun Yat-sen University Cancer Center,Department of Urology
来源：
Journal of Experimental & Clinical Cancer Research | / 33卷
关键词：
Renal cell carcinoma; ETK; Small interfering RNA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Brain Metastases from Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors
    Dudek, Arkadiusz Z.
    Raza, Ahmad
    Chi, Ming
    Singhal, Meghali
    Oberoi, Rajneet
    Mittapalli, Rajendar K.
    Agarwal, Sagar
    Elmquist, William F.
    CLINICAL GENITOURINARY CANCER, 2013, 11 (02) : 155 - 160
  • [22] SPP1 expression indicates outcome of immunotherapy plus tyrosine kinase inhibition in advanced renal cell carcinoma
    Xu, Xianglai
    Lin, Jinglai
    Wang, Jiahao
    Wang, Ying
    Zhu, Yanjun
    Wang, Jiajun
    Guo, Jianming
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [23] Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells
    Guo, Linlang
    Chen, Pinglian
    Zhou, Yuanyuan
    Sun, Yanqin
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2010, 88 (03) : 401 - 406
  • [24] Expression of growth factors and tyrosine kinase receptors in the primary tumor and tumor thrombus cells in patients with renal cell carcinoma
    Volkova, M., I
    Olshanskaya, A. S.
    Tsimafeyeu, I., V
    Vashakmadze, N. L.
    Khochenkova, Yu A.
    Solomko, E. Sh
    Ashuba, S. A.
    Khochenkov, D. A.
    Matveev, V. B.
    ONKOUROLOGIYA, 2020, 16 (01): : 17 - 26
  • [25] Are tyrosine kinase inhibitors fit for purpose in the treatment of metastatic papillary renal cell carcinoma?
    Hemmant, Joshua
    Chow, Karyee
    JOURNAL OF CLINICAL UROLOGY, 2021, 14 (03) : 175 - 178
  • [26] Pazopanib: The newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma
    Keisner S.V.
    Shah S.R.
    Drugs, 2011, 71 (4) : 443 - 454
  • [27] Tyrosine kinase inhibitor as adjuvant treatment of renal cell carcinoma: 1 versus 3
    Penel, Nicolas
    BULLETIN DU CANCER, 2017, 104 (09) : 705 - 706
  • [28] Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy
    L. M. A. Aparicio
    I. P. Fernandez
    J. Cassinello
    Clinical and Translational Oncology, 2017, 19 : 1175 - 1182
  • [29] Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy
    Aparicio, L. M. A.
    Fernandez, I. P.
    Cassinello, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10) : 1175 - 1182
  • [30] Impact of Tyrosine Kinase Inhibitors on the Incidence of Brain Metastasis in Metastatic Renal Cell Carcinoma
    Verma, Jonathan
    Jonasch, Eric
    Allen, Pamela
    Tannir, Nizar
    Mahajan, Anita
    CANCER, 2011, 117 (21) : 4958 - 4965
12345